NPRA1985

NPRA1985 | Joined since 2020-09-03

Investing Experience -
Risk Profile -

Followers

0

Following

0

Blog Posts

0

Threads

3,415

Blogs

Threads

Portfolio

Follower

Following

Summary
Total comments
3,415
Past 30 days
0
Past 7 days
0
Today
0

User Comments
Stock

2020-11-11 10:14 | Report Abuse

SUICIDE halts Brazil trial of Chinese vaccine attacked by Bolsonaro

The trial’s organizers criticized Anvisa’s decision, saying they had not been notified in advance and that there was no reason to stop the trial.

Although a trial volunteer had died, it had nothing to do with the vaccine, Jean Gorinchteyn, Health Secretary for the state of Sao Paulo told a news conference on Tuesday.

“We had an external event that led to the regulator being notified,” Gorinchteyn said. “This vaccine is safe.”

Dimas Covas, the head of Sao Paulo’s medical research institute Butantan, which is conducting the Sinovac trial, said the vaccine had shown no serious adverse effects. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday.

Anvisa said the initial information it received from Butantan had not specified that the death was a SUICIDE.

https://www.reuters.com/article/us-health-coronavirus-brazil-sinovac/suicide-halts-brazil-trial-of-chinese-vaccine-attacked-by-bolsonaro-idUSKBN27Q04C

Stock

2020-11-11 10:13 | Report Abuse

SUICIDE halts Brazil trial of Chinese vaccine attacked by Bolsonaro

The trial’s organizers criticized Anvisa’s decision, saying they had not been notified in advance and that there was no reason to stop the trial.

Although a trial volunteer had died, it had nothing to do with the vaccine, Jean Gorinchteyn, Health Secretary for the state of Sao Paulo told a news conference on Tuesday.

“We had an external event that led to the regulator being notified,” Gorinchteyn said. “This vaccine is safe.”

Dimas Covas, the head of Sao Paulo’s medical research institute Butantan, which is conducting the Sinovac trial, said the vaccine had shown no serious adverse effects. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday.

Anvisa said the initial information it received from Butantan had not specified that the death was a SUICIDE.

https://www.reuters.com/article/us-health-coronavirus-brazil-sinovac/suicide-halts-brazil-trial-of-chinese-vaccine-attacked-by-bolsonaro-idUSKBN27Q04C

Stock

2020-11-11 10:11 | Report Abuse

SUICIDE halts Brazil trial of Chinese vaccine attacked by Bolsonaro

The trial’s organizers criticized Anvisa’s decision, saying they had not been notified in advance and that there was no reason to stop the trial.

Although a trial volunteer had died, it had nothing to do with the vaccine, Jean Gorinchteyn, Health Secretary for the state of Sao Paulo told a news conference on Tuesday.

“We had an external event that led to the regulator being notified,” Gorinchteyn said. “This vaccine is safe.”

Dimas Covas, the head of Sao Paulo’s medical research institute Butantan, which is conducting the Sinovac trial, said the vaccine had shown no serious adverse effects. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday.

Anvisa said the initial information it received from Butantan had not specified that the death was a SUICIDE.

https://www.reuters.com/article/us-health-coronavirus-brazil-sinovac/suicide-halts-brazil-trial-of-chinese-vaccine-attacked-by-bolsonaro-idUSKBN27Q04C

Stock

2020-11-11 10:11 | Report Abuse

SUICIDE halts Brazil trial of Chinese vaccine attacked by Bolsonaro

The trial’s organizers criticized Anvisa’s decision, saying they had not been notified in advance and that there was no reason to stop the trial.

Although a trial volunteer had died, it had nothing to do with the vaccine, Jean Gorinchteyn, Health Secretary for the state of Sao Paulo told a news conference on Tuesday.

“We had an external event that led to the regulator being notified,” Gorinchteyn said. “This vaccine is safe.”

Dimas Covas, the head of Sao Paulo’s medical research institute Butantan, which is conducting the Sinovac trial, said the vaccine had shown no serious adverse effects. Speaking at the same news conference, he said he hoped the trial would be resumed later on Tuesday or Wednesday.

Anvisa said the initial information it received from Butantan had not specified that the death was a SUICIDE.

https://www.reuters.com/article/us-health-coronavirus-brazil-sinovac/suicide-halts-brazil-trial-of-chinese-vaccine-attacked-by-bolsonaro-idUSKBN27Q04C

Stock

2020-11-11 09:59 | Report Abuse

Morocco king orders massive anti-COVID 19 vaccination Op in coming weeks
Vaccination campaign against coronavirus will prioritise front line workers, elderly and vulnerable.

“It is a vaccine ordered from the Chinese laboratory Sinopharm, of which Morocco will receive a batch of 10 million doses,” he added.

https://middle-east-online.com/en/morocco-king-orders-massive-anti-covid-19-vaccination-op-coming-weeks

Stock

2020-11-11 09:56 | Report Abuse

Coronavirus: Bahrain to be among first countries to receive vaccine: Report

He said that Bahrain made an order in August to purchase more than 1 million doses of the Covid-19 vaccines being developed by BioNTech and Pfizer the British firm AstraZeneca and the China’s Sinopharm.

The Kingdom of Bahrain, in cooperation with the UAE, has participated in the Phase 3 clinical trial for a potential Covid-19 vaccine, being developed by Sinopharm.

https://www.khaleejtimes.com/coronavirus-pandemic/coronavirus-bahrain-to-be-among-first-countries-to-receive-vaccine-report

Stock

2020-11-11 00:07 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-11 00:06 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-11 00:05 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-11 00:05 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-11 00:05 | Report Abuse

Sinovac vaccine is not related to any companies in Malaysia but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-11 00:04 | Report Abuse

Sinovac is not related to Kanger but just wanted to share anyway.

------------
Brazilian politics, US pressure likely behind Chinese vaccine's suspension: experts

The Chinese Foreign Ministry, the Chinese vaccine producer and a Brazilian institute clarified that Brazilian health regulator's decision to halt trials of a Chinese-produced COVID-19 vaccine in Brazil is NOT RELATED TO THE VACCINE ITSELF, after foreign media said the suspension came following a "severe adverse event."

Chinese experts said politicization of vaccine issues by some Brazilian politicians was likely the reason. They said the vaccine trial issue, which is life-saving work amid the COVID-19 pandemic, should not be influenced by Brazilian political disputes or US pressure.

They stressed that the vaccine is essential to fight the virus, but the suspension without a reasonable excuse could slow down the vaccine-development process.

Wang Wenbin, spokesperson of the ministry, said at a press conference on Tuesday we notice that BUTANTAN INSTITUTE, partner of China's Sinovac Biotech in Brazil, has concluded that the reported "adverse event" that caused Brazil's health regulator on Monday to suspend trials of a Chinese-produced vaccine in Brazil was NOT RELATED TO THE VACCINE produced by Sinovac.

https://www.globaltimes.cn/content/1206393.shtml

Stock

2020-11-10 23:54 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:53 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:52 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:51 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:50 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:50 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:49 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:49 | Report Abuse

Efficacy of Sinopharm vaccine is higher than Pfizer vaccine. Sinopharm vaccine showed 100% efficacy while Pfizer vaccine only showed 90% efficacy.

-----------

US drug maker Pfizer said its mRNA vaccine candidate is more than 90 percent effective, while SINOPHARM's inactivated vaccine SHOWED 100 PERCENT efficacy at one case in Mexico, both are promising results and have brought about hope of wider use in the fight against the coronavirus, experts said.

Pfizer's announcement got world's attention and many news outlets reported it with enthusiasm, but Sinopharm's vaccine, which have been used on 56,000 people who have traveled abroad, none of whom became infected, were challenged by many Western media when the data was released.

The different reaction revealed Western media's double standard on vaccines for China and the US, with an aim to politicize the issue, Chinese experts said.

Pfizer's 90 percent was based on phase III clinical trials while Sinopharm's is based on observation after emergency use. Although the former has greater authority academically, the latter is also a control study, Tao further explained, noting that the fact 56,000 people did not get infected could serve as a reference for the vaccine's efficacy.

But a major challenge for mRNA vaccines is the temperature requirement for storage - minus 70C for long-term stability in comparison to 2-8 C for the majority of other types of vaccine, Tao noted, "Storage and transportation will be very expensive."

https://www.globaltimes.cn/content/1206389.shtml

Stock

2020-11-10 23:42 | Report Abuse

Morocco’s King Mohammed VI ordered on Monday a massive vaccination campaign against COVID-19 in the coming weeks as the North African kingdom struggles to contain a rapid surge of the coronavirus pandemic.

The North African country is taking part in clinical trials of the vaccine candidate developed by Sinopharm's China National Biotec Group (CNBG), which has agreed to provide Morocco with 10 million doses before the end of the year if results are positive.

“It is a vaccine ordered from the Chinese laboratory Sinopharm, of which Morocco will receive a batch of 10 million doses,” he added.

https://middle-east-online.com/en/morocco-king-orders-massive-anti-covid-19-vaccination-op-coming-weeks

Stock

2020-11-10 22:11 | Report Abuse

Biden targets virus as his White House transition begins

President-elect Joe Biden signaled strongly on Monday that fighting the raging pandemic will be the immediate priority of his new administration, an abrupt shift from President Donald Trump’s more unworried approach to the virus, as the nation surpassed 10 million COVID-19 cases.

Biden began with a direct appeal to all Americans to wear masks, a departure from Trump, who has mocked Biden and others who make a point of always wearing protective face coverings when around others. In an official move, the president-elect formed a coronavirus advisory board dominated by scientists and doctors, while Trump has had a falling out with the medical experts on his own virus task force.

https://apnews.com/article/joe-biden-coronavirus-advisory-board-d7e64d8b270ed3bf8daf58f01775d627

Stock
Stock

2020-11-10 17:04 | Report Abuse

Same here, i am not trading so i am not worried.

Stock

2020-11-10 16:51 | Report Abuse

I no problem as i will be holding for one year.

Stock

2020-11-10 16:45 | Report Abuse

How long can the bull run last? Is it due to vaccine? Just afraid of Biden later.

Stock

2020-11-10 16:45 | Report Abuse

How long can the bull run last? Is it due to vaccine? Just afraid of Biden later.

Stock

2020-11-10 16:45 | Report Abuse

How long can the bull run last? Is it due to vaccine? Just afraid of Biden later.

Stock

2020-11-10 16:44 | Report Abuse

How long can the bull run last? Is it due to vaccine? Just afraid of Biden later.

Stock

2020-11-10 16:44 | Report Abuse

How long can the bull run last? Is it due to vaccine? Just afraid of Biden later.

Stock

2020-11-10 16:37 | Report Abuse

This counter very unpredictable one. Controlled by syndicates and contra players. Just let it be. After a while they will tire themselves out.

Stock
Stock

2020-11-10 12:22 | Report Abuse

Kstar is goreng stock. Might be the next MMAG. Careful.

Stock

2020-11-10 12:13 | Report Abuse

@kamjiat01 Many contra players here. Need to flush them out.

Stock

2020-11-10 12:10 | Report Abuse

Experts all around the world have emphasized again and again. Vaccine must be complemented with face mask and social distancing in order to be effective. Vaccine alone will not help.

Stock

2020-11-10 11:34 | Report Abuse

@bowman Furthermore, Sinopharm is state company. So the government of China will be monitoring very closely to ensure no hanky panky as this is their no. 1 vaccine and they want to make sure it is successful in order to redeem themselves and to rebuild diplomacy with other countries. Their reputation is hinging on this one vaccine.

Stock

2020-11-10 11:26 | Report Abuse

The side effect reported for Sinovac may be a sliver lining. One less competitor for Sinopharm Vaccine. Maybe after this, countries which had MOU/deals/ agreements with Sinovac will switch to Sinopharm instead.

Stock

2020-11-10 11:21 | Report Abuse

Anyways think about it Pfizer vaccine requires -70C storage versus Sinopharm vaccine 2-8C. Which is more practical for South East Asia countries, including Malaysia?

Stock

2020-11-10 11:11 | Report Abuse

@huatkopi88 No. Sinovac and Sinopharm 2 different companies.

Stock

2020-11-10 10:54 | Report Abuse

Sinopharm has experience with WHO prequalification. They have vaccines that have been prequalified by WHO prior to this. Besides, they are working very closely with WHO on the phase III trial of Sinopharm vaccine. Hence, safety and efficacy is not an issue with Sinopharm Vaccine.

Stock

2020-11-10 10:47 | Report Abuse

@amanbetta. Sinovac is NOT related to Kanger. Kanger is tied to Sinopharm.

Stock

2020-11-10 10:45 | Report Abuse

@ amanbetta Sinovac vaccine nothing to do with Kanger. Please my post above.

Stock

2020-11-10 10:41 | Report Abuse

@yanz77 NONE. No stocks related to Sinovac Vaccine in Malaysia.

Stock

2020-11-10 10:40 | Report Abuse

Besides, as i pointed above, Sinopharm phase III trial in UASE is the largest in the world which has the best chance of detecting any rare or serious side effects. So far, there are no serious side effects reported in the UAE trial. The vaccine has been reported to be safe and effective so far.

Stock

2020-11-10 10:39 | Report Abuse

@al8000 That is Sinovac Vaccine not related to Kanger. Kanger is tied to Sinopharm